Rankings
▼
Calendar
ACHV Q4 2024 Earnings — Achieve Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena
ACHV
Achieve Life Sciences, Inc.
$233M
Q4 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$12M
Net Income
-$12M
EPS (Diluted)
$-0.36
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$39M
Total Liabilities
$18M
Stockholders' Equity
$21M
Cash & Equivalents
$13M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$12M
-$4M
-177.9%
Net Income
-$12M
-$5M
-125.7%
← FY 2024
All Quarters
Q1 2025 →